InTRODUCTIOn
Although the treatment for peptic ulcer disease (PUD) has changed, the perforated ulcer -one of the most important complications -, did not present any important benefits. The incidence of perforated ulcer disease has remained virtually unchanged over the years 11 . Being the main cause of mortality on peptic ulcer disease 4 , the perforation affects patients in different age groups, young or elder (20-40%) 26 , indicating the importance and severity of this disease.
The association between Helicobacter pylori and peptic disease is well established in the literature and in medical practice. Such connection has changed considerably the usual therapy 10 . The role of the bacteria on peptic ulcer disease complications -like perforation -, is matter of discussion, concerning what would be the best surgical treatment for it: simple closure with omentopexy or acidreduction surgeries. Inasmuch, peptic ulcer disease relapse rate after simple closure was too high, and so acid reduction surgery became the treatment of choice for perforated ulcers 14 . However, studies have shown that simple closure followed by H. pylori eradication diminished relapse rate 1, 3, 7, 12, 15, 16, 18, 19, 20, 21, 24, 28 . Furthermore, shorter surgery time and easiness of the technique have encouraged surgeons to adopt this procedure in these situations.
The aim of this study is to analyze the relapse rate of peptic ulcer disease in patients with perforated ulcer, H. pylori positives, submitted to simple suture of the lesion, omentopexy and eradication of the bacteria, and compare the data with a H. pylori negative group submitted to the same surgical treatment.
METhODS
All patients admitted in Emergency Service of University Hospital of Santa Maria's, Santa Maria, RS, Brasil, with acute abdominal pain due to perforated prepyloric, pyloric our duodenal peptic ulcer disease -confirmed by laparotomy -, from June 1997 to July 2007, were included in this study after a study's agreement term.
According to study's protocol, once the perforated gastric or duodenal ulcer was confirmed, all patients were submitted to its suture with omentopexy 13 , plus the usual procedures for peritonitis -cavity washing -biopsies or resection of gastric lesions.
On the 30th post-operative day, with absence of any antibiotics or proton pump inhibitor drugs for at least ten days, all patients were submitted to a upper endoscopy to evaluate the ulcerous lesion and the presence of H. pylori infection. Two methods were used: random biopsies of the pyloric antrum and gastric body for histopathologic examination under Giemsa stain, and the urease test read within 24 hours. Also, a gastritis severity stratification was done in slight, mild or severe. Infection was considered positive results when it was confirmed by both exams.
According to these results, the patients were divided into two groups, based on the presence of H. pylori infection: the negative and the positive. The positive were treated with the association of amoxicillin, clarithromycin and proton pump inhibitor for seven days, aiming to eradicate the bacteria. Ninety days after the treatment was finished, the patients were submitted to a second upper endoscopy. The ones with a negative result were considered eradicated. The positive were submitted to the same treatment for 14 days, and the endoscopy was repeated 90 days after the treatment was concluded. Negative results were considered free of colonization; positive ones were considered not eradicable.
After the first upper endoscopy, all patients were required to attend to out-patient service every six months for sequential endoscopies, aiming to verify the status of the ulcer and the presence of H. pylori.
All ulcers detected in the serial endoscopies were considered as relapses, exception made for the ones found in the first follow-up exam. In these cases, the lesions detected were seen as residual or under healing process.
All patients with positive results for H. pylori after previous eradication were considered reinfected.
The statistical analysis was performed using Chi-square with Yates correction and Fisher's exact test to compare proportions, and Student t test for numeric data. The significance value considered was 0,05.
RESULTS
The initial amount of 144 patients had 14 nosocomial deceases (9,7%), 44 exclusion due to protocol errors, incorrect diagnosis (mostly perforated gastric adenocarcinomas), ulcers at locations other than pyloric or prepyloric, or non-attendance for the first upper endoscopy. After the first endoscopy, 35 patients were excluded due to out-patient follow-up dropout or discordance on H. pylori detection tests. The remaining 51 patients were included in the study.
These patients were divided into two groups, according to the presence or absence of H. pylori infection. The group considered positive for the infection included 25 patients -21 men and four women -, with an average age of 44,73 years. Two patients (8%) were considered not eradicable according to the protocol criteria and were excluded from the final analysis. Both relapsed and one was submitted to truncal vagotomy plus Billroth I procedure, and the other one asymptomatic refused surgery. The remaining patients were eradicated from H. pylori and followed-up for an average period of 38,21 months. They were submitted to 5,65 upper endoscopies per patient. Relapse was detected in four patients (17,39%), half of them (8,69%) presented with reinfection. The group considered negative for H. pylori included 26 patients -20 men and six women -, aging 49,84 years. The follow-up period was 38,38 months with an average of 5,03 endoscopies per patient. Relapse was detected on eight patients in this group (30,76%).
The statistic comparison between the two groups concerning relapse did not show any difference for P=0,05 (Table 1) .
DISCUSSIOn
The treatment for perforated ulcer is surgical in the majority of the cases, but the technique to be used is controversial. One option -simple closure -proved to result in high relapse rates (36,6% at 36 months 2 and 52% at 54 months 5 ). Acid-reduction surgery is another option, but it carries on higher morbidity and mortality rates 8, 25 . In 1984, Marshall, et al. 17 identified the bacteria Helicobacter pylori as the aetiological agent, introducing a new element for this discussion.
Studies have widely demonstrated that the eradication of H. pylori diminishes relapse rates of non-complicated cases 10 . But, the effect of H. pylori eradication in complications of this disease, like perforation, is still a matter of research. From the year of 1995 on, several publications demonstrated that the simple closure of perforated ulcers, plus the eradication of H. pylori, diminishes relapse rates significantly, inducing this strategy as treatment for this complication 1, 3, 7, 12, 15, 16, 18, 19, 20, 21, 24, 28 . Historically, Sebastian, et al. 24 were the first to suggest association between H. pylori Ten-years comparative study after surgical treatment of perforated peptic ulcer according to ulcer relapse between H. Pylori positive, after eradication, and negative patients infection and peptic ulcer disease's relapse. The mortality (9,7%) in this study is corroborated by the literature. Sweeney, et al. 27 reported mortality rates of 3-18%, considering age, perforation time and comorbidities.
This study had a substantial dropout rate from the initial patient number (51%). Ng, et al. 20 had a dropout rate of 48%. The low adherence to this study can be justified by the following reasons: the hospital is difficult in access to other cities; the population related to it is mostly of low social level; and most patients were asymptomatic during the follow-up period.
Incidence of H. pylori infection on patients with perforation varies greatly amongst the various studies found in the literature. There are several different methods used for detecting the bacteria on each study, and different criteria used by each researcher to confirm the infection. The infection rate was of 49%, using urease test and histopathologic analysis with positivity required on both. Kumar, et al. 16 and Chu, et al. 6 used the same positivity criteria on their study (56% and 47,2% infection rate, respectively). Tran and Quandalle 28 used three diagnostic tests: urease, histopathologic and serologic, requiring positivity in only one (96% infection rate). Gisbert, et al. 12 revised the literature on this subject, finding an average incidence of 68%.
The exclusion criteria for this study removed patients with gastric ulcers other than pyloric or prepyloric. Rodriguez-Sanjuan, et al. 21 also removed those patients, as they presented with a higher rate of ulcer re-perforation. These authors also contraindicate closure of gastric ulcers of locations other than those, for the relapse rate is too high.
Concerning the suspension time for the PPI drugs before the first endoscopy, Bose, et al. 3 and Ng, et al. 20 suspended the drug 30 days before the H. pylori detection tests were performed. This study suspended the drug at least 10 days before the tests. Since the incidence of H. pylori infection is similar to the one found in the literature, it's possible to assume that difference did not interfered on the results here presented.
The eradication rate (92%) is also similar to the ones found in the literature. Tran, et al. 28 reported 95% and Metzger, et al. 19 96%. An important detail that has been neglected by these authors is the reinfection rate. This study revealed a reinfection of 8,69% over an average follow-up period of three years, similar to the one found by Schutze, et al. 23 .
Concerning the main goal of this study, the detection relapse on patients without infection or eradicated from H. pylori, there are some important matters to consider: this relapse rate for patients initially eradicated was of 17,39%, whilst half of them (8,69%) were reinfected patients, eligible for another eradication attempt. The relapse rate for patients that remained H. pylori negative during follow-up was of 30%. Bose, et al. 3 , with an average follow-up time of 18 months, accounted a relapse rate of 18,6% for the eradicated patients. Ng, et al. 20 reported a 38% relapse rate for the patients treated with an omeprazole monotherapy against a 4,8% rate for eradicated patients with a 12 months follow-up period. Rodriguez-Sanjuan, et al. 21 related a 6,1% relapse rate for eradicated patients, with a 22 months follow-up period. This author, however, performed upper endoscopies on patients according to surgeon's criterion.
Laparotomic or laparoscopic suture of the ulcer, followed by omentopexy, should be the treatment of choice for perforated duodenal, pyloric or prepyloric ulcer, when associated with H. pylori infection. The low mortality and relapse rates of this technique, plus its simplicity to be performed, justify its election. However, there is another significant group of patients: chronic users of non-steroidal anti-inflammatory drugs (NSAIDs), usually above 60 years old and H. pylori-negative, which do not deserve eradication treatment.
For this last group of patients, on the impossibility of discontinuing the anti-inflammatory drugs, the associated use of PPIs did not reduce the risks of ulcer bleeding and perforation satisfactorily. Rostom, et al.
22
, over wide review, concluded that any PPI drug was effective in reducing the incidence of peptic ulcer disease on chronic NSAID users; however, only misoprostol reduced the risk of complications like bleeding and perforation.
COnCLUSIOn
During a perforated ulcer surgical handling, random specimens of the gastric antrum and body should be collected for rapid urease test. If it is positive for H. pylori, the preferable procedure is perforation suture with omentopexy for duodenal ulcers, and ulcerectomy with closure for gastric ulcers. If the test is negative, an acid-reduction surgery is recommended.
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